Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
Sarepta Therapeutics, Inc. (SRPT)
Today's Latest Price: $127.90 USD
2.40 (-1.84%)
Updated Jan 17 12:00am
Add SRPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SRPT Stock Summary
- Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 14.94% of US stocks have a lower such ratio.
- With a price/sales ratio of 26.59, Sarepta Therapeutics Inc has a higher such ratio than 95.26% of stocks in our set.
- Over the past twelve months, SRPT has reported earnings growth of 170.12%, putting it ahead of 93% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Sarepta Therapeutics Inc are PTCT, OMEX, MTEM, PGNX, and DNN.
- Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to www.sarepta.com.
SRPT Daily Price Range
SRPT 52-Week Price Range
SRPT Stock Price Chart More Charts
SRPT Price/Volume Stats
| Current price | $127.90 | 52-week high | $158.80 |
| Prev. close | $130.30 | 52-week low | $72.05 |
| Day low | $127.44 | Volume | 862,500 |
| Day high | $131.24 | Avg. volume | 967,067 |
| 50-day MA | $116.12 | Dividend yield | N/A |
| 200-day MA | $114.32 | Market Cap | 9.53B |
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...